A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter

LaBarbera, K. M., Sheline, Y. I., Izzo, N. J., Yuede, C. M., Waybright, L., Yurko, R., … Hamby, M. E. (2023, December 1). A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter. Translational Neurodegeneration. BioMed Central Ltd. https://doi.org/10.1186/s40035-023-00358-w